日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hypomethylating Agents and Venetoclax Based Triplets Targeting FLT3, IDH and KMT2A in Acute Myeloid Leukemia: Current Studies and Challenges of a Tailored Approach

针对急性髓系白血病中 FLT3、IDH 和 KMT2A 的去甲基化药物和基于维奈托克的联合疗法:当前研究及个体化治疗的挑战

Santambrogio, Elisa; Castellino, Alessia; Audisio, Ernesta; Schumacher, Martin; Feldmann, Georg; Iftikhar, Raheel; Brossart, Peter; Aydin, Semra

Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial

Hevylite 检测对接受 GMMG-MM5 试验治疗的 IgG 或 IgA 多发性骨髓瘤患者的预后影响

Richardson, Tim; Mai, Elias; Menis, Ekaterina; Benner, Axel; Tichy, Diana; Miah, Kaya; Hänel, Mathias; Besemer, Britta; Boquoi, Amelie; Blau, Igor Wolfgang; Michel, Christian S; Lindemann, Hans Walter; Janjetovic, Snjezana; Brossart, Peter; Bernhard, Helga; Reimer, Peter; Salwender, Hans; Hose, Dirk; Seckinger, Anja; Raab, Marc; Goldschmidt, Hartmut; Scheid, Christof

Targeting cancer: tumor-specific splicing events give rise to immunogenic, tumor-wide neoantigens

靶向癌症:肿瘤特异性剪接事件产生具有免疫原性的肿瘤内新抗原

Kosiol, Nils; Heine, Annkristin; Brossart, Peter

Author Correction: Autologous T cell therapy for PRAME(+) advanced solid tumors in HLA-A*02(+) patients: a phase 1 trial

作者更正:自体T细胞疗法治疗HLA-A*02(+)患者的PRAME(+)晚期实体瘤:一项I期试验

Wermke, Martin; Araujo, Dejka M; Chatterjee, Manik; Tsimberidou, Apostolia M; Holderried, Tobias A W; Jazaeri, Amir A; Reshef, Ran; Bokemeyer, Carsten; Alsdorf, Winfried; Wetzko, Katrin; Brossart, Peter; Aslan, Katrin; Backert, Linus; Bunk, Sebastian; Fritsche, Jens; Gulde, Swapna; Hengler, Silvana; Hilf, Norbert; Hossain, Mohammad B; Hukelmann, Jens; Kalra, Mamta; Krishna, Delfi; Kursunel, M Alper; Maurer, Dominik; Mayer-Mokler, Andrea; Mendrzyk, Regina; Mohamed, Ali; Pozo, Karine; Satelli, Arun; Letizia, Marilena; Schuster, Heiko; Schoor, Oliver; Wagner, Claudia; Rammensee, Hans-Georg; Reinhardt, Carsten; Singh-Jasuja, Harpreet; Walter, Steffen; Weinschenk, Toni; Luke, Jason J; Britten, Cedrik M

Autologous T cell therapy for PRAME(+) advanced solid tumors in HLA-A*02(+) patients: a phase 1 trial

自体T细胞疗法治疗HLA-A*02(+)患者的PRAME(+)晚期实体瘤:一项I期试验

Wermke, Martin; Araujo, Dejka M; Chatterjee, Manik; Tsimberidou, Apostolia M; Holderried, Tobias A W; Jazaeri, Amir A; Reshef, Ran; Bokemeyer, Carsten; Alsdorf, Winfried; Wetzko, Katrin; Brossart, Peter; Aslan, Katrin; Backert, Linus; Bunk, Sebastian; Fritsche, Jens; Gulde, Swapna; Hengler, Silvana; Hilf, Norbert; Hossain, Mohammad B; Hukelmann, Jens; Kalra, Mamta; Krishna, Delfi; Kursunel, M Alper; Maurer, Dominik; Mayer-Mokler, Andrea; Mendrzyk, Regina; Mohamed, Ali; Pozo, Karine; Satelli, Arun; Letizia, Marilena; Schuster, Heiko; Schoor, Oliver; Wagner, Claudia; Rammensee, Hans-Georg; Reinhardt, Carsten; Singh-Jasuja, Harpreet; Walter, Steffen; Weinschenk, Toni; Luke, Jason J; Britten, Cedrik M

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

复发性多发性骨髓瘤的挽救性自体移植:GMMG ReLApsE III期试验的长期随访

Baertsch, Marc-Andrea; Schlenzka, Jana; Hielscher, Thomas; Raab, Marc S; Sauer, Sandra; Merz, Maximilian; Mai, Elias Karl; Müller-Tidow, Carsten; Luntz, Steffen; Jauch, Anna; Brossart, Peter; Goerner, Martin; Klein, Stefan; Glass, Bertram; Reimer, Peter; Graeven, Ullrich; Fenk, Roland; Haenel, Mathias; von Metzler, Ivana; Lindemann, Hans W; Scheid, Christof; Blau, Igor-Wolfgang; Salwender, Hans J; Noppeney, Richard; Besemer, Britta; Weisel, Katja C; Goldschmidt, Hartmut

Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy

免疫疗法改良分类中进展性疾病模式的剖析

Saal, Jonas; Eckstein, Markus; Ritter, Manuel; Brossart, Peter; Luetkens, Julian; Ellinger, Jörg; Grünwald, Viktor; Hölzel, Michael; Klümper, Niklas

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

一项针对晚期黑色素瘤、皮肤鳞状细胞癌、头颈部鳞状细胞癌或腺样囊性癌患者的瘤内注射CV8102的I期研究

Eigentler, Thomas; Thomas, Ioannis; Samoylenko, Igor; Erdmann, Michael; Heinzerling, Lucie; Ochsenreither, Sebastian; Krauss, Jürgen; Oberoi, Arjun; Robert, Caroline; Lebbe, Celeste; Martin-Liberal, Juan; Koch, Lukas; Richtig, Erika; Terheyden, Patrick; Weishaupt, Carsten; Mohr, Peter; Semiletova, Yulia; Perez, Casilda Llacer; Brossart, Peter; Bauernfeind, Franz Georg; Fluck, Michael; Poltoratskiy, Artem; Sekacheva, Marina; Soria, Ainara; Schmitt-Bormann, Beate; Gonzalez, Marina; Heß, Jana; Wengenmayer, Peter; Seibel, Tobias; Koch, Sven D; Quintini, Gianluca; Codó, Paula; Falk, Martin; Schönborn-Kellenberger, Oliver; Gnad-Vogt, Ulrike

Dexamethasone induced Dectin-1 activation enhances NLRP3 inflammasome activation

地塞米松诱导的Dectin-1激活增强NLRP3炎症小体的激活

Koerber, Ruth-Miriam; Oberbeck, Sebastian; Kotthoff, Philipp; Daecke, Solveig N; Brossart, Peter; Held, Stefanie A E

On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information

在接受阿特珠单抗和贝伐珠单抗治疗的肝细胞癌患者中,治疗期间改良的格拉斯哥预后评分(mGPS)可提供预后信息。

Hattenhauer, Tessa; Mispelbaum, Rebekka; Heine, Annkristin; Schwab, Katjana; Brossart, Peter; Klümper, Niklas; Saal, Jonas